跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAN-LEVETIRACETAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VAN-LEVETIRACETAM
Authorized
STANDARD
VAN-LEVETIRACETAM
vanc pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bb59f3616e3440e8
Company
vanc pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
bb59f3616e3440e8
Drug Approval Canada Name
VAN-LEVETIRACETAM
Product Name
VAN-LEVETIRACETAM
Status
Cancelled Post Market
Status Date
2019-08-07
Original Market Date
2016-04-04
Din
02432374
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX14 LEVETIRACETAM
Atc Name
n 03 ax 14
Aig Number
0148843001
Company Name
vanc pharmaceuticals inc
Company Address
2639 Viking Way, Unit 210, Richmond, British Columbia, Canada, V6V 3B7
Active Ingredients
LEVETIRACETAM
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bb59f3616e3440e8
Type
Standard
Back to Health Canada Approvals